Main menu button

News

Carlsquare SaaSalon Berlin
17 Mar 2026
Carlsquare SaaSalon Berlin
Events
Equity research Pila Pharma H1 2026: From rat detour to clinical heat
28 Aug 2026
Equity research Pila Pharma H1 2026: From rat detour to clinical heat
Equity Research Pila Pharma
Equity research Zinzino Q2 2026: Strong profitability trend
26 Aug 2026
Equity research Zinzino Q2 2026: Strong profitability trend
Equity Research Zinzino
Equity research WPTG, Q2 2026: AI pivot accelerates growth and margins
26 Aug 2026
Equity research WPTG, Q2 2026: AI pivot accelerates growth and margins
Equity Research White Pearl Technology Group
Carlsquare advised curea and Mérieux on on the arrangement of a construction facility to finance curea's new headquarters
26 Aug 2026
Carlsquare advised curea and Mérieux on on the arrangement of a construction facility to finance curea's new headquarters
Deal News
Equity research Zinzino Q2 2026: First impression - ZZ tops estimates, maintains outlook
25 Aug 2026
Equity research Zinzino Q2 2026: First impression - ZZ tops estimates, maintains outlook
Equity Research Zinzino
Equity research Viva Wine Group Q2 2026: Margin relief in a soft market
21 Aug 2026
Equity research Viva Wine Group Q2 2026: Margin relief in a soft market
Equity Research Viva Wine Group
Equity research Angler Gaming, Q2 2026: Growth confirmed, margins at new highs
21 Aug 2026
Equity research Angler Gaming, Q2 2026: Growth confirmed, margins at new highs
Equity Research Angler Gaming
Equity research Angler Gaming, Q2 2026: Revenue and EBIT beat
20 Aug 2026
Equity research Angler Gaming, Q2 2026: Revenue and EBIT beat
Equity Research Angler Gaming
Equity research Viva Wine Group Q2 2026: First impression - EBITA beat despite soft organic growth
20 Aug 2026
Equity research Viva Wine Group Q2 2026: First impression - EBITA beat despite soft organic growth
Equity Research Viva Wine Group
Equity research Pila Pharma: Receives go-ahead for start of obesity trials
18 Aug 2026
Equity research Pila Pharma: Receives go-ahead for start of obesity trials
Equity Research Pila Pharma
Carlsquare London – Rooftop Cocktails 2026
18 Aug 2026
Carlsquare London – Rooftop Cocktails 2026
Events
Carlsquare advised Reproflex Scandinavia A/S on the sale to FPI Group AB
17 Aug 2026
Carlsquare advised Reproflex Scandinavia A/S on the sale to FPI Group AB
Deal News
Mark Miller on Building a Global 200-Employee M&A Firm | New Podcast Episode
14 Aug 2026
Mark Miller on Building a Global 200-Employee M&A Firm | New Podcast Episode
In the Media
Carlsquare advised Netwise on its sale to collana Group, a portfolio company of Ufenau Capital Partners
13 Aug 2026
Carlsquare advised Netwise on its sale to collana Group, a portfolio company of Ufenau Capital Partners
Deal News
Analys Elicera Therapeutics: Lovande data från upploppet av CARMA-studiens första del
11 Aug 2026
Analys Elicera Therapeutics: Lovande data från upploppet av CARMA-studiens första del
Equity Research Elicera Therapeutics
European Debt Markets: Quarterly Insights #3 2026
10 Aug 2026
European Debt Markets: Quarterly Insights #3 2026
Insights
FINANCE ranks Carlsquare among Germany’s most active debt advisers in 2026
07 Aug 2026
FINANCE ranks Carlsquare among Germany’s most active debt advisers in 2026
Company News
Equity research Immunovia, Q2 2026: MediCare submission and partnerships in focus
07 Aug 2026
Equity research Immunovia, Q2 2026: MediCare submission and partnerships in focus
Equity Research Immunovia
Carlsquare Private Equity Insights: Q2 2026
06 Aug 2026
Carlsquare Private Equity Insights: Q2 2026
Insights
SAP in 2026: AI-Enabled or AI-Disrupted?
03 Aug 2026
SAP in 2026: AI-Enabled or AI-Disrupted?
Insights